Bond.az White LogoBond.az Black Logo

Wolfe Research Cuts Lowe's Price Target on Weak Demand

Wolfe Research lowers Lowe's price target to $254 on muted demand outlook, maintaining Outperform rating.

Sophia Anderson
BySophia Anderson- Senior Editor
|
0

Wolfe Research lowered its price target on Lowe's Companies Inc. (NYSE:LOW) to $254 from $288 while maintaining an Outperform rating. Shares currently trade at $221.05, near their 52-week low of $208.

The firm cited the home improvement retailer's results that missed expectations and commentary on second-quarter-to-date performance that was more subdued than anticipated.

Wolfe Research expects muted demand to persist through 2026 and likely into 2027. The analyst comments, "Lowe's results missed expectations and commentary on 2QTD was more muted than we had anticipated. As a result, we continue to expect muted demand through '26 and likely into '27 as higher rates and the lock-in effect remain a persistent overhang on the sector."

Despite near-term headwinds, the stock trades at a P/E ratio of 18.46 and offers a 2.17% dividend yield. According to Bond.az analysis, the stock appears overvalued relative to its Fair Value.

Higher interest rates and the lock-in effect are expected to remain a persistent overhang on the home improvement sector.

The firm maintained its Outperform rating despite the reduced price target.

More News
2026-06-01 12:02
|
743

Legend Biotech Buy Rating Reiterated

H.C. Wainwright reiterated its Buy rating for Legend Biotech with a $50 target. Revenue up 56% over twelve months.

0
2026-06-01 12:01
|
475

Cogent Stock Price Target Raised to $55

Cogent Biosciences PEAK trial: combination therapy shows 45.6% response rate, 16.5 months PFS, FDA accepts NDA. H.C. Wainwright raises price target to $55.

0
2026-06-01 12:00
|
842

H.C. Wainwright Reaffirms Mineralys Buy

H.C. Wainwright reiterated a Buy rating on Mineralys Therapeutics with a $56 price target after positive trial data.

0
2026-06-01 10:33
|
714

Goldman Sachs Upgrades Marriott Vacations Stock

Goldman Sachs upgrades Marriott Vacations stock to Buy, price target $100. Execution potential drives earnings upside.

0
2026-06-01 10:32
|
730

Goldman Sachs Upgrades Travel + Leisure Stock to Buy

Goldman Sachs upgraded Travel + Leisure stock to Buy with a $85 price target. Learn about the company's financials, dividends, and market outlook.

0
2026-06-01 10:32
|
238

Canaccord Initiates Rare Earths Americas with Buy

Canaccord Genuity initiates Rare Earths Americas with a buy rating and $25 target. Stock at $21.85, offering 14% upside potential.

0
2026-06-01 10:30
|
651

BofA Raises Icon Stock Target to $125 on Bookings

BofA Securities raised Icon plc price target to $125, maintains Underperform. Improved booking trends and Q4 results drive revision.

0
2026-06-01 10:03
|
748

RBC Capital: Sprouts faces Kroger risk

RBC Capital keeps Sprouts rating but sees risks from Kroger price cuts. Analysis and outlook on Bond.az.

0
2026-06-01 09:02
|
551

CLSA Rates Chagee Hold on Margins

CLSA initiated Chagee Holdings with Hold rating and $10 target. Bond.az analysis reveals stock may be undervalued. Read more.

0
2026-06-01 08:31
|
594

Barclays Downgrades Sensata Stock on Valuation

Barclays downgrades Sensata stock to Equalweight on valuation concerns, but raises price target to $53. Stock surged 92% in past year.

0
2026-06-01 08:05
|
946

UBS Initiates Veritone Coverage with Neutral

UBS initiated coverage on Veritone with a Neutral rating and $2.50 price target. The AI company is better positioned for growth after transformation.

0
2026-06-01 08:02
|
892

JMP Securities Initiates Microsoft with Outperform on AI Strategy

JMP Securities initiates Microsoft with Market Outperform rating and $550 target on AI strategy. Revenue growth expected to reach 17% in FY2026.

0
...
Wolfe Research Cuts Lowe's Price Target on Weak Demand | Bond.az